An ongoing dialogue on HIV/AIDS, infectious diseases,
January 4th, 2009
Top Stories in HIV Medicine
Happy New Year!
In the spirit of list-making that seems to permeate the world right about this time, we’ve just published our own list over at AIDS Clinical Care. Check it out — our editorial board this year did a superb job of summarizing the field.
I have a strong feeling that next year’s version will have some much more hopeful news on prevention, perhaps through pre-exposure prophylaxis (PrEP), or treatment as prevention, or both.
As for advances in vaccines, um … perhaps the less said the better?
Categories: Health Care, HIV, Infectious Diseases, Medical Education, Patient Care
Tags: Abacavir, antiretroviral therapy, HIV, HIV testing, PrEP, prevention, testing, vaccines
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
One Response to “Top Stories in HIV Medicine”

Paul E. Sax, MD
Contributing Editor
NEJM Journal Watch
Infectious Diseases
Biography | Disclosures | Summaries
Learn more about HIV and ID Observations.
Follow HIV and ID Observations Posts via Email
- The Short Political Half-life of a Medical Contrarian
- Who Gets Sent to ID Clinic? A Field Guide to Outpatient Referrals
- Anal Cancer Screening in HIV: When Guidelines Get Ahead of the Evidence
- Does the Fact That AI Is Brilliant at Writing “Learning Objectives” Prove They’re Not Really Needed?
- Ceftriaxone Is a Narrow Antibiotic Now — and Other Musings
- ID Cartoon Caption Contest (125)
- ID Cartoon Caption Contest #2 Winner — and a New Contest for the Holidays (92)
- Dear Nation — A Series of Apologies on COVID-19 (80)
- How to Induce Rage in a Doctor (77)
- IDSA’s COVID-19 Treatment Guidelines Highlight Difficulty of “Don’t Just Do Something, Stand There” (74)
-
NEJM Journal Watch — Recent Infectious Disease Articles
- The Season for Tick-Borne Infection Is Lengthening in New England
- Neisseria gonorrhoeae Answers Back to DoxyPEP
- Observations from ID and Beyond: Anal Cancer Screening in HIV: When Guidelines Get Ahead of the Evidence
- Managing Complicated Urinary Tract Infections
- Dalbavancin for Management of Enterococcus faecalis Infection: A Word of Caution
-
Tag Cloud
- Abacavir AIDS antibiotics antiretroviral therapy ART atazanavir baseball Brush with Greatness CDC C diff COVID-19 CROI darunavir dolutegravir elvitegravir etravirine FDA HCV hepatitis C HIV HIV cure HIV testing ID fellowship ID Learning Unit Infectious Diseases influenza Link-o-Rama lyme disease MRSA PEP Policy PrEP prevention primary care raltegravir Really Rapid Review resistance Retrovirus Conference rilpivirine sofosbuvir TDF/FTC tenofovir Thanksgiving vaccines zoster
South Africa has 600 000 new HIV infections EACH year!
“Add HIV/Aids to list of 32 notifyable diseases, or be negligent!